Recent Events

MP-SPECT by Eagle Heart Imaging, LLC





Understanding the Current Status of Nuclear Cardiology.



The recent publication by Shaw, et al, (1) [J Nucl Cardiol 2012;19:1026-43] regarding the present status and future prospects for myocardial perfusion imaging (MPI) ignores one of the most import facts essential for understanding this issue and correctly addressing the fundamental inadequacy of MPI as a first line diagnostic screening tool for CAD. Figure 2 of this article clearly presents the specificity for detection of CAD by standard rotational SPECT MPI to be 74%. This value has been previously corroborated by De Prez, et al (2) in a literature review commissioned by ASNC and published in the Journal of Nuclear Cardiology (JNC). The De Prez report examined the costeffectiveness of MPI and stated that “1 in 4 of the normal patients undergoing MPI for detection of CAD is likely to have a falsely abnormal finding”. This reality has influenced all parties concerned about the clinical efficacy of MPI, including third-party payers, to critically scrutinize the degree to which MPI is being utilized for clinical diagnosis and calls into question its cost-effectiveness. Shaw, et al, fail to discuss this issue.


Closer examination of the information in Figure 2 of (1) sheds further light on the most probable cause for this deficiency. Note that the adjacent bar graph for PET MPI shows the specificity to be 85% in comparison to the value of 74% stated for SPECT MPI. The tracers and study protocols for these two modalities (SPECT vs PET) are comparable and several clinical comparison studies have indicated diagnostic accuracies consistent with the values given in Figure 2 of (1). However, the literature lacks any coherent, testable explanation for this outcome. What needs to be kept in mind is that the most significant difference between these two technologies is that all PET imaging systems remain completely stationary during image acquisition, whereas standard rotational SPECT image data is acquired sequentially in a step-and-shoot fashion. Gantry rotation routinely takes 10 to 20 minutes allowing adequate time for many changes to take place.


A teaching editorial by Bacharach (3) also published in JNC discusses the inevitability of artifacts generated in rotational SPECT cardiac images resulting from “inconsistencies in the sequentially acquired image data” caused by the propensity for patient movement, including coughing, creep, and additional data discrepancies resulting from stress induced physiologic changes in cardiac volume over time. This would include, for instance, transient ischemic dilation (TID). Available information clearly points to the mathematics of SPECT image reconstruction is being intrinsically prone to generate false positive findings in the presence of such inconsistencies and the frequency of these artifacts is the engine that drives the unacceptably high false positive rate. Efforts to train clinicians to“read around” such artifacts have not produced acceptable results.


Also appearing recently in JNC (4) is the description of two multi-pinhole SPECT devices that acquire MPI without movement of either the detector or the collimator. One of these devices (the Discovery NM 530c, GE Healthcare, Milwaukee, WI) has been commercially available since 2008 and published reports demonstrate “improved clarity” in the clinical images generated by this system. Unfortunately, the GE Discovery system utilizes expensive solid-state CZT detectors which exhibit spectral distortion characteristics that are very different from those of NaI(Tl). This distortion in CZT performance creates ambiguity between Compton scatter and primary gammas which has prevented the GE device from providing adequate Compton scatter subtraction or “simultaneous imaging of Tc- 99m and Tl-201", as had been anticipated in (4). If achieved, this could greatly improve the imaging efficiency and diagnostic accuracy of MPI.


Reference (1) ends with optimistic anticipation stating that the authors “look forward to the completion of the upcoming randomized trials and the development of the American Society of Nuclear Cardiology registries on radiation safety and Appropriate Use Criterion to further unfold the body of evidence on the utility of MPI as central to patient-centered imaging strategies of care.” Sending 1 in 4 normal patients for unnecessary cardiac catheterization is not an appropriate use of ionizing radiation.


Collectively, the information presented herein from JNC references (2-4) along with the data contained in Figure 2 of reference (1) itself, point to the need for a coordinated review of all currently available data. Before we can embrace the rosy view of the future prospects for MPI contained in the conclusion of (1). There needs to be a comprehensive understanding of where nuclear cardiology actually is now and how it got there, along with full acknowledgment of the factors that will continue to limit the diagnostic specificity of standard rotational SPECT MPI to 74%. Then we can begin to understand how stationary multi-pinhole SPECT systems can perform when correctly designed and applied. There is no satisfactory explanation as to why the diagnostic specificity of SPECT MPI is below 85% offered in (1) and failure to achieve this level of accuracy will continue to increase pressure to limit the clinical utilization of SPECT MPI.


What is needed now is for innovative scientists, clinicians, technologists and manufacturers to move forward, guided by a consistent, workable and testable understanding of the engineering principles and physiologic mechanisms which underlie nuclear cardiology. The historic belief that rotational SPECT MPI as it presently exists can adequately meet the future needs to detect and manage CAD is flawed and retention of this misguided notion will contribute to further deterioration of the clinical role of MPI. As we enter an era of outcome guided medical management, simultaneous, dual-isotope MPI by multi-pinhole SPECT technique holds the key to accurate, reliable, cost-effective MPI..



  1. Shaw LJ, Hage FG, Berman DS, et al, Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? J Nucl Cardiol 2012;19:1026-43.
  2. Des Prez, RD, Shaw LJ, Gillespie, RL, et al. Cost-effectiveness of myocardial perfusion imaging: A summary of the currently available literature. J Nucl Cardiol 2005;12:750-9.
  3. Bacharach SL. Why does SPECT work? (editorial). J Nucl Cardiol 2006;13:313-5.
  4. Slomka, PJ, Patton JA, Daniel S. Berman, MD, Guido Gemano, et al. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol 2009;16:255-76.